» Articles » PMID: 26224476

Prognostic Significance of Human Tissue Kallikrein-related Peptidases 11 and 15 in Gastric Cancer

Overview
Journal Tumour Biol
Publisher Sage Publications
Specialty Oncology
Date 2015 Jul 31
PMID 26224476
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Human tissue kallikrein-related peptidases (KLK) are a group of 15 serine proteases which have been investigated as potential cancer biomarkers. This study determined the prognostic significance of KLK 11 and 15 expression levels in gastric carcinoma specimens. Expression of KLK11 and KLK15 was assessed by immunohistochemistry staining on a tissue microarray constructed from 113 gastrectomy specimens from patients with gastric carcinoma. To minimize inter-observer variability, expression levels were quantified using an automated algorithm. Epithelial and stromal staining were assessed separately. Both KLK11 and KLK15 were expressed in gastric carcinoma. There was no significant correlation between either KLK11 or KLK15 expression and the presence of lymph node metastases or Lauren classification (intestinal vs. diffuse). Higher levels of KLK11 expression in gastric carcinoma were associated with significantly worse overall survival (p = 0.008), and a multivariate analysis showed that it had prognostic value independent of tumor stage and differentiation (p = 0.004). Variations in KLK15 expression were not significantly associated with prognosis. KLK11 shows promise as a potential independent prognostic marker for gastric carcinoma.

Citing Articles

The identification of genes associated T-cell exhaustion and construction of prognostic signature to predict immunotherapy response in lung adenocarcinoma.

Wu Y, Du B, Lin M, Ji X, Lv C, Lai J Sci Rep. 2023; 13(1):13415.

PMID: 37592010 PMC: 10435542. DOI: 10.1038/s41598-023-40662-z.


Remodelling of the tumour microenvironment by the kallikrein-related peptidases.

Srinivasan S, Kryza T, Batra J, Clements J Nat Rev Cancer. 2022; 22(4):223-238.

PMID: 35102281 DOI: 10.1038/s41568-021-00436-z.


Kallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters.

Ozturk T, Kain E, Tuzuner M, Diren A, Batur S, Yilmaz-Aydogan H In Vivo. 2021; 35(6):3233-3243.

PMID: 34697154 PMC: 8627752. DOI: 10.21873/invivo.12618.


Kallikrein-11, in Association with Coiled-Coil Domain Containing 25, as a Potential Prognostic Marker for Cholangiocarcinoma with Lymph Node Metastasis.

Siriphak S, Chanakankun R, Proungvitaya T, Roytrakul S, Tummanatsakun D, Seubwai W Molecules. 2021; 26(11).

PMID: 34067437 PMC: 8196963. DOI: 10.3390/molecules26113105.


KLK11 suppresses cellular proliferation via inhibition of Wnt/β-catenin signaling pathway in esophageal squamous cell carcinoma.

He X, Meng F, Qin L, Liu Z, Zhu X, Yu Z Am J Cancer Res. 2019; 9(10):2264-2277.

PMID: 31720087 PMC: 6834484.


References
1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

2.
Yousef G, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C . Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J Clin Oncol. 2003; 21(16):3119-26. DOI: 10.1200/JCO.2003.09.111. View

3.
Gravalos C, Jimeno A . HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008; 19(9):1523-9. DOI: 10.1093/annonc/mdn169. View

4.
Patsis C, Yiotakis I, Scorilas A . Diagnostic and prognostic significance of human kallikrein 11 (KLK11) mRNA expression levels in patients with laryngeal cancer. Clin Biochem. 2012; 45(9):623-30. DOI: 10.1016/j.clinbiochem.2012.03.005. View

5.
Shah M, Ajani J . Gastric cancer--an enigmatic and heterogeneous disease. JAMA. 2010; 303(17):1753-4. DOI: 10.1001/jama.2010.553. View